Harper G. Hubbeling
Radiation Oncology
3400 Civic Center Boulevard
West Pavilion, 2nd Floor
Philadelphia, PA 19104
West Pavilion, 2nd Floor
Philadelphia, PA 19104
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
Safe Integration of Radiation Therapy With Bispecific Antibodies in Relapsed/Refractory B-cell Lymphomas.
Journal: Clinical lymphoma, myeloma & leukemia
Published: April 30, 2026
Clinical, molecular, and immunologic determinants of survival in WHO-defined IDH-wildtype glioblastoma treated with radiotherapy: a large real-world cohort study.
Journal: Journal of neuro-oncology
Published: March 11, 2026
Hypofractionated Proton Reirradiation for Recurrent Glioblastoma: Clinical and Dosimetric Outcomes from a Large Single Institution Series.
Journal: International journal of radiation oncology, biology, physics
Published: January 15, 2026
Hypofractionated Proton Reirradiation for Recurrent Glioblastoma: Clinical and Dosimetric Outcomes from a Large Single-Institution Series.
Journal: International journal of radiation oncology, biology, physics
Published: January 15, 2026
Safety of Concurrent Systemic Therapy and Total Skin Electron Therapy in Cutaneous T-Cell Lymphoma.
Journal: Clinical lymphoma, myeloma & leukemia
Published: January 09, 2026
Long Term Results of Proton Therapy in Adult Infradiaphragmatic Lymphoma.
Journal: International journal of particle therapy
Published: December 28, 2025
Standard Versus Hypofractionated Low-Dose Total Skin Electron Therapy for Cutaneous T-Cell Lymphoma: A Single-Institution Retrospective Analysis.
Journal: Practical radiation oncology
Published: December 16, 2025
Outcomes after SRS and ipilimumab plus nivolumab for melanoma brain metastases following prior immune checkpoint inhibitor or targeted therapy.
Journal: The oncologist
Published: November 07, 2025
Last Updated: 09/26/2026